International safety notice
Janus kinase inhibitors (JAKi) – Updated recommendations to minimise risks associated with medicine
Ireland / HPRA · IRL · Mar 13, 2023
Key facts
| Title | Janus kinase inhibitors (JAKi) – Updated recommendations to minimise risks associated with medicine |
|---|---|
| Regulator | Ireland / HPRA |
| Country | IRL |
| Brand | Janus kinase inhibitors (JAKi) – Updated recommendations to minimise risks associated with medicine |
| Models | 386.4, 00800, A3921133, 316-326, 4FAUNITED, DHPC3 |
| Date | Mar 13, 2023 |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1